Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 92Nasopharyngeal Carcinoma 35Nasopharyngeal Neoplasms 15Laryngeal Neoplasms 12Oropharyngeal Neoplasms 10Mouth Neoplasms 10Hypopharyngeal Neoplasms 9Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Carcinoma, Squamous Cell 7Neoplasm Metastasis 6Esophageal Neoplasms 6Carcinoma 6Stomach Neoplasms 5Tongue Neoplasms 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Ovarian Neoplasms 4Laryngeal Diseases 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Thyroid Neoplasms 2Pharyngeal Neoplasms 2

Interventions

pembrolizumab 1Radiotherapy 1Oncolytic Virotherapy 1Hydroxyurea 1Fluorouracil 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nose Neoplasms × Fluorouracil × Head & Neck × Clear all
NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡